These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 11806093)
1. Safety and effectiveness of oral quinidine in cardioversion of persistent atrial fibrillation. Kirpizidis C; Stavrati A; Geleris P; Boudoulas H J Cardiol; 2001 Dec; 38(6):351-4. PubMed ID: 11806093 [TBL] [Abstract][Full Text] [Related]
2. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation. Kerin NZ; Faitel K; Naini M Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696 [TBL] [Abstract][Full Text] [Related]
3. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods. Naegeli B; Straumann E; Bertel O Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188 [TBL] [Abstract][Full Text] [Related]
4. [Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation]. Zehender M; Meinertz T; Just H Z Kardiol; 1994; 83 Suppl 5():101-8. PubMed ID: 7846938 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of amiodarone and quinidine in the conversion to sinusal rhythm of atrial fibrillation of recent onset]. Negrini M; Gibelli G; De Ponti C G Ital Cardiol; 1990 Mar; 20(3):207-14. PubMed ID: 2344898 [TBL] [Abstract][Full Text] [Related]
6. [Predictors of efficacy initial low energy of external rectilinear biphasic cardioversion in persistent atrial fibrillation]. Górecki AI; Stec S; Kucharska I; Wełnicki M; Zaborska B; Kryński T; Kułakowski P Pol Merkur Lekarski; 2007 Dec; 23(138):408-12. PubMed ID: 18432122 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation]. Vainer J; Smíd J; Cepeláková H; Hapala J; Topinka I; Topolcan O Vnitr Lek; 1989 Feb; 35(2):145-50. PubMed ID: 2711622 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium]. Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735 [TBL] [Abstract][Full Text] [Related]
9. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Wozakowska-Kapłon B; Opolski G Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030 [TBL] [Abstract][Full Text] [Related]
10. [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison]. Kalusche D; Stockinger J; Betz P; Roskamm H Z Kardiol; 1994; 83 Suppl 5():109-16. PubMed ID: 7846939 [TBL] [Abstract][Full Text] [Related]
11. Transesophageal electrical cardioversion of persistent atrial fibrillation: a new approach for an old technology. Zardo F; Brieda M; Hrovatin E; Dametto E; Cassin M; Sparacino L; Cervesato E; Nicolosi GL Ital Heart J; 2002 Jun; 3(6):354-9. PubMed ID: 12116799 [TBL] [Abstract][Full Text] [Related]
12. Electrical cardioversion for persistent or chronic atrial fibrillation: outcome and clinical factors predicting short and long term success rate. Blich M; Edoute Y Int J Cardiol; 2006 Mar; 107(3):389-94. PubMed ID: 16503261 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA; Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716 [TBL] [Abstract][Full Text] [Related]
15. [The use of digitalis glycosides in atrial fibrillation]. Knez A; Haberl R; Steinbeck G Z Kardiol; 1994; 83 Suppl 5():71-3. PubMed ID: 7846948 [TBL] [Abstract][Full Text] [Related]
16. Increase in QT/QTc dispersion after low energy cardioversion of chronic persistent atrial fibrillation. Boriani G; Valzania C; Biffi M; Corazza I; Camanini C; Martignani C; Bacchi L; Zannoli R; Branzi A Int J Cardiol; 2004 Jun; 95(2-3):245-50. PubMed ID: 15193827 [TBL] [Abstract][Full Text] [Related]
17. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G; Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102 [TBL] [Abstract][Full Text] [Related]
18. Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling. Zohar P; Kovacic M; Brezocnik M; Podbregar M Europace; 2005 Sep; 7(5):500-7. PubMed ID: 16087117 [TBL] [Abstract][Full Text] [Related]
19. Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone. Kapoor A; Kumar S; Singh RK; Pandey CM; Sinha N J Heart Valve Dis; 2002 Nov; 11(6):802-9. PubMed ID: 12479281 [TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation: rate control often better than rhythm control. Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]